![]() |
FAQ/Help |
Calendar |
Search |
#1
|
|||
|
|||
I've read that a company in/around Boston ("Euthymics") has developed a triple reuptake inhibitor (it "does" serotonin, dopamine and Norepinephrine)...I was wondering if anyone knew its status (still in trials/studies, approved for use, awaiting approval, etc.)
__________________
"Psychiatric diagnoses are very useful metaphors." |
Reply |
|